Spots Global Cancer Trial Database for lineberger comprehensive cancer center
Every month we try and update this database with for lineberger comprehensive cancer center cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas | NCT01263418 | Lymphoma, Non-H... Lymphoma, Folli... Lymphoma, B-Cel... Lymphoma, Low-G... Lymphoma, Inter... | Ofatumumab | 70 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma | NCT01234467 | Diffuse Large B... Lymphoma, Diffu... Diffuse Large-C... Lymphoma | Bendamustine Rituximab | 65 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Neoadjuvant Pazopanib in Renal Cell Carcinoma | NCT01361113 | Renal Cell Carc... | Pazopanib | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Neoadjuvant Pazopanib in Renal Cell Carcinoma | NCT01361113 | Renal Cell Carc... | Pazopanib | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer | NCT01300962 | Metastatic Brea... | BMK120 Capecitabine BYL719 Trastuzumab Lapatinib | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma | NCT01234467 | Diffuse Large B... Lymphoma, Diffu... Diffuse Large-C... Lymphoma | Bendamustine Rituximab | 65 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma | NCT01234467 | Diffuse Large B... Lymphoma, Diffu... Diffuse Large-C... Lymphoma | Bendamustine Rituximab | 65 Years - | UNC Lineberger Comprehensive Cancer Center | |
| PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias | NCT01169012 | Myelodysplastic... Acute Myeloid L... Acute Lymphobla... Chronic Myelomo... | Clofarabine | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases | NCT01305941 | HER-2 Positive ... | Everolimus Vinorelbine Trastuzumab | 21 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer | NCT02008058 | Metastatic Cast... | Survey | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell Lymphomas | NCT02700022 | Diffuse Large B... Follicular Lymp... Burkitt Lymphom... | Alisertib | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer | NCT01300962 | Metastatic Brea... | BMK120 Capecitabine BYL719 Trastuzumab Lapatinib | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases | NCT01305941 | HER-2 Positive ... | Everolimus Vinorelbine Trastuzumab | 21 Years - | UNC Lineberger Comprehensive Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
